What C70 covers · when clinicians use it
ICD-10 code C70 identifies Malignant neoplasm of meninges in the U.S. ICD-10-CM clinical and billing record set. It sits within the Neoplasms chapter (C00–D49), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply C70 when an encounter's findings match the Malignant neoplasm of meninges description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify C70 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for C70 and is a coding reference, not clinical, diagnostic, or billing advice.
C70 refers to Malignant neoplasm of meninges, a group of central nervous system and ocular malignancies. These tumors may be aggressive and present with neurological or vision-related symptoms. ICD10 coding for these conditions ensures accurate diagnosis documentation, facilitates multidisciplinary care, and supports outcomes tracking.
Symptoms
- Headaches – Persistent and often worse in the morning (brain or meningeal tumors)
- Vision changes – Blurred or loss of vision with ocular or optic pathway tumors
- Seizures – Common in brain malignancies
- Numbness or weakness – Seen with spinal or cranial nerve involvement
- Balance or coordination issues – Particularly with cerebellar or brainstem tumors
- Cognitive or personality changes – Indicative of frontal lobe tumors
- Eye pain or swelling – Seen in eye and adnexal cancers
Diagnosis
Diagnosis of Malignant neoplasm of meninges includes neuroimaging (MRI, CT), ophthalmic exam (for C69), lumbar puncture (for meningeal involvement), and biopsy. Functional imaging and neurophysiological tests may be used to assess tumor impact. Multidisciplinary evaluation helps determine surgical, radiological, or chemotherapeutic strategies.
ICD10 Code Usage
ICD10 code C70 is used in neurology, oncology, neurosurgery, and ophthalmology to classify cancers of the brain, meninges, spinal cord, and eye. It supports accurate treatment coding, insurance claims, and cancer registry tracking.
Related Codes
- C69 – Malignant neoplasm of eye and adnexa
- C71 – Malignant neoplasm of brain
- C72 – Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
FAQs
Q1: What is ICD10 code C70?
A: It refers to Malignant neoplasm of meninges, used to classify malignant tumors affecting the brain, eye, and nervous system.
Q2: Are these tumors common?
A: Brain tumors are relatively rare but serious. Eye and meningeal tumors are less common and often aggressive.
Q3: What is the treatment approach?
A: Surgery, radiation therapy, chemotherapy, or targeted therapy depending on tumor type and location.
Q4: Can these tumors spread?
A: Yes, some can spread to or from other areas of the CNS or metastasize systemically.
Q5: How important is early diagnosis?
A: Critical—early intervention improves outcomes, especially with highly invasive or function-impairing tumors.
Conclusion
ICD10 code C70 is vital for documenting and managing Malignant neoplasm of meninges. It enables timely referrals, treatment planning, insurance coverage, and epidemiological tracking. Accurate coding also contributes to research efforts and clinical decision-making in neuro-oncology.